Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats

Neuroscience

Volumn 97, Issue 2, 2000, Pages 285-291

  Lu, X ^a   Bing, G ^b   Hagg, T ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

Cell death; Inflammation; Lipopolysaccharide; Microglial activation; Opioid; Parkinson's disease

Indexed keywords

LIPOPOLYSACCHARIDE; NALOXONE; OPIATE RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; HISTOLOGY; INFLAMMATION; MICROGLIA; NERVE CELL DEGENERATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; CELL DEATH; CELL SURVIVAL; DOPAMINE; LIPOPOLYSACCHARIDES; MICROGLIA; NALOXONE; NERVE DEGENERATION; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANTIA NIGRA;

EID: 0034008991     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(00)00033-6     Document Type: Article

References (80)

1. Appel E., Kolman O., Kazimirsky G., Blumberg P.M., Brodie C. Regulation of GDNF expression in cultured astrocytes by inflammatory stimuli. NeuroReport. 8:1997;3309-3312.
2. Banati R.B., Gehrmann J., Schubert P., Kreutzberg G.W. Cytotoxicity of microglia. Glia. 7:1993;111-118.
3. Becher B., Antel J.P. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia. 18:1996;1-10.
4. Bolton S.J., Perry V.H. Histone H1; a neuronal protein that binds bacterial lipopolysaccharide. J. Neurocytol. 26:1997;823-831.
5. Bozzi Y., Borrelli E. Absence of the dopamine D2 receptor leads to a decreased expression of GDNF and NT-4 mRNAs in restricted brain areas. Eur. J. Neurosci. 11:1999;1275-1284.
6. Bronstein D.M., Perez-Otano I., Sun V., Mullis-Sawin S.B., Chan J., Wu G.C., Hudson P.M., Kong L.Y., Hong J.S., McMillian M.K. Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res. 704:1995;112-116.
7. Buttini M., Appel K., Sauter A., Gebicke-Haerter P.J., Boddeke H.W. Expression of tumor necrosis factor alpha after focal cerebral ischaemia in the rat. Neuroscience. 71:1996;1-16.
8. Casamenti F., Prosperi C., Scali C., Giovannelli L., Pepeu G. Morphological, biochemical and behavioural changes induced by neurotoxic and inflammatory insults to the nucleus basalis. Int. J. dev. Neurosci. 16:1998;705-714.
9. Castano A., Herrera A.J., Cano J., Machado A. Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J. Neurochem. 70:1998;1584-1592.
10. Chamberlain J.M., Klein B.L. A comprehensive review of naloxone for the emergency physician. Am. J. emerg. Med. 12:1994;650-660.
11. Chao C.C., Gekker G., Sheng W.S., Hu S., Tsang M., Peterson P.K. Priming effect of morphine on the production of tumor necrosis factor-alpha by microglia: implications in respiratory burst activity and human immunodeficiency virus-1 expression. J. Pharmac. exp. Ther. 269:1994;198-203.
12. Chen C.C., Wang J.K., Chen W.C., Lin S.B. Protein kinase C eta mediates lipopolysaccharide-induced nitric-oxide synthase expression in primary astrocytes. J. biol. Chem. 273:1998;19,424-19,430.
13. Das K.P., McMillian M.K., Bing G., Hong J.S. Modulatory effects of [Met5]-enkephalin on interleukin-1 beta secretion from microglia in mixed brain cell cultures. J. Neuroimmunol. 62:1995;9-17.
14. Di-Chiara G., Imperato A. Opposite effects of mu and kappa opiate agonists on dopamine release in the nucleus accumbens and in the dorsal caudate of freely moving rats. J. Pharmac. exp. Ther. 244:1988;1067-1080.
15. Dickson D.W., Lee S.C., Mattiace L.A., Yen S.H., Brosnan C. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia. 7:1993;75-83.
16. Dobrenis K., Makman M.H., Stefano G.B. Occurrence of the opiate alkaloid-selective mu3 receptor in mammalian microglia, astrocytes and Kupffer cells. Brain Res. 686:1995;239-248.
17. Enrico P., Esposito G., Mura M.A., Fresu L., De-Natale G., Miele E., Desole M.S., Miele M. Effect of morphine on striatal dopamine metabolism and ascorbic and uric acid release in freely moving rats. Brain Res. 745:1997;173-182.
18. Enrico P., Mura M.A., Esposito G., Serra P., Migheli R., De-Natale G., Desole M.S., Miele M., Miele E. Effect of naloxone on morphine-induced changes in striatal dopamine metabolism and glutamate, ascorbic acid and uric acid release in freely moving rats. Brain Res. 797:1998;94-102.
19. Fearnley J.M., Lees A.J. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 114:1991;2283-2301.
20. Feigenbaum J.J., Howard S.G. The effect of naloxone on spontaneous and evoked dopamine release in the central and peripheral nervous systems. Life Sci. 59:1996;2009-2019.
21. Feigenbaum J.J., Howard S.G. Effects of naloxone on amphetamine induced striatal dopamine release in vivo: a microdialysis study. Life Sci. 60:1997;1659-1668.
22. Galve-Roperh I., Malpartida J.M., Haro A., Brachet P., Diaz-Laviada I. Regulation of nerve growth factor secretion and mRNA expression by bacterial lipopolysaccharide in primary cultures of rat astrocytes. J. Neurosci. Res. 49:1997;569-575.
23. Gehrmann J., Matsumoto Y., Kreutzberg G.W. Microglia: intrinsic immuneffector cell of the brain. Brain Res. Rev. 20:1995;269-287.
24. Georges F., Normand E., Bloch B., Le-Moine C. Opioid receptor gene expression in the rat brain during ontogeny, with special reference to the mesostriatal system: an in situ hybridization study. Devl Brain. Res. 109:1998;187-199.
25. Gonzalez-Scarano F., Baltuch G. Microglia as mediators of inflammatory and degenerative diseases. A. Rev. Neurosci. 22:1999;219-240.
26. Goureau O., Regnier-Ricard F., Courtois Y. Requirement for nitric oxide in retinal neuronal cell death induced by activated Muller glial cells. J. Neurochem. 72:1999;2506-2515.
27. Hagg T., Varon S. Ciliary neurotrophic factor prevents degeneration of adult rat substantia nigra dopaminergic neurons in vivo. Proc. natn. Acad. Sci. U.S.A. 90:1993;6315-6319.
28. Havenith C.E., Askew D., Walker W.S. Mouse resident microglia: isolation and characterization of immunoregulatory properties with naive CD4+ and CD8+ T-cells. Glia. 22:1998;348-359.
29. Heneka M.T., Loschmann P.A., Gleichmann M., Weller M., Schulz J.B., Wullner U., Klockgether T. Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J. Neurochem. 71:1998;88-94.
30. Heneka M.T., Schmidlin A., Wiesinger H. Induction of argininosuccinate synthetase in rat brain glial cells after striatal microinjection of immunostimulants. J. cerebr. Blood Flow Metab. 19:1999;898-907.
31. Hu S., Martella A., Anderson W.R., Chao C.C. Role of cytokines in lipopolysaccharide-induced functional and structural abnormalities of astrocytes. Glia. 10:1994;227-234.
32. Inoue S., Susukida M., Ikeda K., Murase K., Hayashi K. Dopaminergic transmitter up-regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) synthesis in mouse astrocytes in culture. Biochem. biophys. Res. Commun. 238:1997;468-472.
33. Johnson S.W., North R.A. Opioids excite dopamine neurons by hyperpolarization of local interneurons. J. Neurosci. 12:1992;483-488.
34. Kalaria R.N. Microglia and Alzheimer's disease. Curr. Opin. Hematol. 6:1999;15-24.
35. Kischka U., Farber S.A., Marshall D., Wurtman R.J. Carbachol and naloxone synergistically elevate dopamine release in rat striatum: an in vivo microdialysis study. Brain Res. 613:1993;288-290.
36. Kitamura Y., Takahashi H., Matsuoka Y., Tooyama I., Kimura H., Nomura Y., Taniguchi T. In vivo induction of inducible nitric oxide synthase by microinjection with interferon-gamma and lipopolysaccharide in rat hippocampus. Glia. 18:1996;233-243.
37. Klegeris A., Walker D.G., McGeer P.L. Regulation of glutamate in cultures of human monocytic THP-1 and astrocytoma U-373 MG cells. J. Neuroimmunol. 78:1997;152-161.
38. Kong L.Y., Hudson P.M., Wilson B.C., Lu X., Hong J.S. Inhibition of lipopolysaccharide-induced neurotoxicity in mixed cortical neuron/glia cultures by naloxone and opiate-related compounds. Soc. Neurosci. Abstr. 23:1997;719.
39. Kong L.Y., McMillian M.K., Hudson P.M., Jin L., Hong J.S. Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphis in mixed glia cultures. J. Pharmac. exp. Ther. 280:1997;61-66.
40. Lacroix S., Feinstein D., Rivest S. The bacterial endotoxin lipopolysaccharide has the ability to target the brain in upregulating its membrane CD14 receptor within specific cellular populations. Brain Pathol. 8:1998;625-640.
41. Lawson L.J., Perry V.H., Dri P., Gordon S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience. 39:1990;151-170.
42. Lu X., Hagg T. Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats. J. comp. Neurol. 388:1997;484-494.
43. Mansour A.H.K., Lewis M., Akil H., Watson S.J. Anatomy of CNS opiod receptors. Trends Neurosci. 11:1988;308-314.
44. Matsuoka Y., Kitamura Y., Takahashi H., Tooyama I., Kimura H., Gebicke-Haerter P.J., Nomura Y., Taniguchi T. Interferon-gamma plus lipopolysaccharide induction of delayed neuronal apoptosis in rat hippocampus. Neurochem. Int. 34:1999;91-99.
45. McGeer E.G., McGeer P.L. The importance of inflammatory mechanisms in Alzheimer disease. Expl Gerontol. 33:1998;371-378.
46. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 38:1988;1285-1291.
47. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Rev. 21:1995;195-218.
48. Minghetti L., Levi G. Microglia as effector cells in brain damage and repair: focus on prostanoids and nitric oxide. Prog. Neurobiol. 54:1998;99-125.
49. Miranda A.F., Boegman R.J., Beninger R.J., Jhamandas K. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid. Neuroscience. 78:1997;967-975.
50. Miwa T., Furukawa S., Nakajima K., Furukawa Y., Kohsaka S. Lipopolysaccharide enhances synthesis of brain-derived neurotrophic factor in cultured rat microglia. J. Neurosci. Res. 50:1997;1023-1029.
51. Moore S., Thanos S. The concept of microglia in relation to central nervous system disease and regeneration. Prog. Neurobiol. 48:1996;441-460.
52. Mulder A.H., Wardeh G., Hogenboom F., Frankhuyzen A.L. Kappa- and delta-opioid receptor agonists differentially inhibit striatal dopamine and acetylcholine release. Nature. 308:1984;278-280.
53. Okazawa H., Murata M., Watanabe M., Kamei M., Kanazawa I. Dopaminergic stimulation up-regulates the in vivo expression of brain-derived neurotrophic factor (BDNF) in the striatum. Fedn Eur. biochem. Socs Lett. 313:1992;138-142.
54. Ostrowski N.L., Pert A. Substantia nigra opiate receptors on basal ganglia efferents. Brain Res. Bull. 38:1995;513-523.
55. Ota A., Yoshida S., Nomura T., Matsui S., Hagino Y., Umezawa K., Katoh S., Nagatsu T. Tetrahydrobiopterin biosynthesis enhanced by lipopolysaccharide stimulation in murine neuroblastoma cell line N1E-115. J. Neurochem. 67:1996;2540-2548.
56. Patrizio M., Levi G. Glutamate production by cultured microglia: differences between rat and mouse, enhancement by lipopolysaccharide and lack effect of HIV coat protein gp120 and depolarizing agents. Neurosci. Lett. 178:1994;184-189.
57. Patterson P.H. Cytokines in Alzheimer's disease and multiple sclerosis. Curr. Opin. Neurobiol. 5:1995;642-646.
58. Perry V.H. A revised view of the central nervous system microenvironment and major histocompatibility complex class II antigen presentation. J. Neuroimmunol. 90:1998;113-121.
59. Perry V.H., Gordon S. Macrophages and the nervous system. Int. Rev. Cytol. 125:1991;203-244.
60. Plunkett R.J., Ip N.Y., Asada H., Friedman B., Pan L., Kaseloo P.A., Parfitt M.M. Trauma-induced striatal CNTF and BDNF mRNA in hemiparkinsonian rats. NeuroReport. 8:1997;507-511.
61. Rogers J., Kirby L.C., Hempelman S.R., Berry D.L., McGeer P.L., Kaszniak A.W., Zalinski J., Cofield M., Mansukhani L., Willson P., Kogan F. Clinical trial of indomethacin in Alzheimer's disease. Neurology. 43:1993;1609-1611.
62. Rogove A.D., Tsirka S.E. Neurotoxic responses by microglia elicited by excitotoxic injury in the mouse hippocampus. Curr. Biol. 8:1998;19-25.
63. Roy S., Barke R.A., Loh H.H. MU-opioid receptor-knockout mice: role of mu-opioid receptor in morphine mediated immune functions. Molec. Brain Res. 61:1998;190-194.
64. Sato I., Himi T., Murota S. Lipopolysaccharide-induced nitric oxide synthase activity in cultured cerebellar granule neurons. Neurosci. Lett. 205:1996;45-48.
65. Schmidlin A., Wiesinger H. Argininosuccinate synthetase: localization in astrocytes and role in the production of glial nitric oxide. Glia. 24:1998;428-436.
66. Schumann R.R., Pfeil D., Freyer D., Buerger W., Lamping N., Kirschning C.J., Goebel U.B., Weber J.R. Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes. Glia. 22:1998;295-305.
67. Sedgwick J.D., Schwender S., Imrich H., Dorries R., Butcher G.W., ter-Meulen V. Isolation and direct characterization of resident microglial cells from the normal and inflamed central nervous system. Proc. natn. Acad. Sci. U.S.A. 88:1991;7438-7442.
68. Skaper S.D., Facci L., Leon A. Inflammatory mediator stimulation of astrocytes and meningeal fibroblasts induces neuronal degeneration via the nitridergic pathway. J. Neurochem. 64:1995;266-276.
69. Streit W.J. The role of microglia in brain injury. Neurotoxicology. 17:1996;671-678.
70. Streit W.J., Graeber M.B., Kreutzberg G.W. Functional plasticity of microglia: a review. Glia. 1:1988;301-307.
71. Takeuchi A., Isobe K.I., Miyaishi O., Sawada M., Fan Z.H., Nakashima I., Kiuchi K. Microglial NO induces delayed neuronal death following acute injury in the striatum. Eur. J. Neurosci. 10:1998;1613-1620.
72. Thanos S., Mey J., Wild M. Treatment of the adult retina with microglia-suppressing factors retards axotomy-induced neuronal degradation and enhances axonal regeneration in vivo and in vitro. J. Neurosci. 13:1993;455-466.
73. Ulvestad E., Williams K., Mork S., Antel J., Nyland H. Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro. J. Neuropath. exp. Neurol. 53:1994;492-501.
74. Walker J.M., Thompson L.A., Frascella J., Friederich M.W. Opposite effects of mu and kappa opiates on the firing-rate of dopamine cells in the substantia nigra of the rat. Eur. J. Pharmac. 134:1987;53-59.
75. Wang Y.S., White T.D. The bacterial endotoxin lipopolysaccharide causes rapid inappropriate excitation in rat cortex. J. Neurochem. 72:1999;652-660.
76. Willard L.B., Hauss-Wegrzyniak B., Wenk G.L. Pathological and biochemical consequences of acute and chronic neuroinflammation within the basal forebrain cholinergic system of rats. Neuroscience. 88:1999;193-200.
77. Yamada K., Komori Y., Tanaka T., Senzaki K., Nikai T., Sugihara H., Kameyama T., Nabeshima T. Brain dysfunction associated with an induction of nitric oxide synthase following an intracerebral injection of lipopolysaccharide in rats. Neuroscience. 88:1999;281-294.
78. You Z.B., Herrera-Marschitz M., Nylander I., Goiny M., Kehr J., Ungerstedt U., Terenius L. Effect of morphine on dynorphin B and GABA release in the basal ganglia of rats. Brain Res. 710:1996;241-248.
79. Yrjanheikki J., Keinanen R., Pellikka M., Hokfelt T., Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. natn. Acad. Sci. U.S.A. 95:1998;15,769-15,774.
80. Zietlow R., Dunnett S.B., Fawcett J.W. The effect of microglia on embryonic dopaminergic neuronal survival in vitro: diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective. Eur. J. Neurosci. 11:1999;1657-1667.